Clinical Trials

    A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

    Investigator: Jun Zhang

    Study Coordinator: Johnnie Young

    Status: Enrolling

    ClinicalTrials.gov Number: NCT07227597

    Phone: 346.238.5839

    Protocol Number: PRO00042030

    Description


    Researchers are looking for new ways to treat extensive-stage small cell lung cancer (ES-SCLC). ES-SCLC is a type of lung cancer that has spread throughout the lung, to the other lung, or to other parts of the body. A standard (usual) treatment for ES-SCLC uses both chemotherapy and immunotherapy.